ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 161,707 | 67,757 | 53,234 | 56,281 | 63,385 |
| Receivables | 172,925 | 174,713 | 165,438 | 140,433 | 150,410 |
| Inventories | 104,323 | 103,654 | 105,355 | 95,893 | 92,545 |
| Other current assets | 8,020 | 8,020 | 8,020 | 8,020 | 8,020 |
| TOTAL | $459,311 | $364,753 | $344,261 | $309,377 | $322,399 |
| Non-Current Assets | |||||
| PPE Net | 44,371 | 43,275 | 43,246 | 42,830 | 43,771 |
| Intangibles | 258,520 | 267,012 | 279,856 | 292,458 | 297,814 |
| Other Non-Current Assets | 97,139 | 90,184 | 92,724 | 94,445 | 87,350 |
| TOTAL | $400,030 | $400,471 | $415,826 | $429,733 | $428,935 |
| Total Assets | $859,341 | $765,224 | $760,087 | $739,110 | $751,334 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 850 | 850 | 850 | 850 | 850 |
| Accounts payable and accrued liabilities | 28,505 | 32,687 | 29,305 | 18,992 | 27,641 |
| Accrued Expenses | 68,485 | 69,527 | 69,284 | 61,785 | 67,821 |
| Other current liabilities | 25,025 | 22,761 | N/A | N/A | N/A |
| TOTAL | $122,865 | $125,825 | $99,439 | $81,627 | $96,312 |
| Non-Current Liabilities | |||||
| Long Term Debt | 285,244 | 285,457 | 285,669 | 285,882 | 286,095 |
| Other Non-Current Liabilities | 16,760 | 14,460 | 36,439 | 34,926 | 31,969 |
| TOTAL | $302,004 | $299,917 | $322,108 | $320,808 | $318,064 |
| Total Liabilities | $424,869 | $425,742 | $421,547 | $402,435 | $414,376 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,292 | 17,974 | 17,504 | 17,465 | 17,437 |
| Common Shares | 2 | 1 | 1 | 1 | 1 |
| Retained earnings | -90,414 | -96,252 | -97,286 | -92,636 | -83,630 |
| Other shareholders' equity | 38,396 | 36,338 | 36,924 | 34,914 | 30,544 |
| TOTAL | $434,472 | $339,482 | $338,540 | $336,675 | $336,958 |
| Total Liabilities And Equity | $859,341 | $765,224 | $760,087 | $739,110 | $751,334 |